Spots Global Cancer Trial Database for gynecological
Every month we try and update this database with for gynecological cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | NCT02744898 | Endometrial Can... | Carboplatin AUC Abraxane | 18 Years - | NYU Langone Health | |
Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project | NCT01691144 | Endometrial Can... Ovarian Cancer Cervical Cancer | 19 Years - | University of Oslo | ||
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA) | NCT04699071 | Adenocarcinomas Recurrent Gynec... | pembrolizumab a... | 21 Years - 99 Years | National University Hospital, Singapore | |
Accelerating Gastrointestinal Recovery | NCT01704651 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Alvimopan Placebo | 18 Years - | Mayo Clinic | |
Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project | NCT01691144 | Endometrial Can... Ovarian Cancer Cervical Cancer | 19 Years - | University of Oslo | ||
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA) | NCT04699071 | Adenocarcinomas Recurrent Gynec... | pembrolizumab a... | 21 Years - 99 Years | National University Hospital, Singapore | |
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus | NCT02744898 | Endometrial Can... | Carboplatin AUC Abraxane | 18 Years - | NYU Langone Health |